Champions Oncology (CSBR) Net Margin (2016 - 2025)
Historic Net Margin for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to 1.58%.
- Champions Oncology's Net Margin fell 38200.0% to 1.58% in Q4 2025 from the same period last year, while for Oct 2025 it was 4.16%, marking a year-over-year increase of 52800.0%. This contributed to the annual value of 8.26% for FY2025, which is 227600.0% up from last year.
- Champions Oncology's Net Margin amounted to 1.58% in Q4 2025, which was down 38200.0% from 3.33% recorded in Q3 2025.
- Champions Oncology's Net Margin's 5-year high stood at 26.38% during Q1 2025, with a 5-year trough of 21.05% in Q1 2024.
- In the last 5 years, Champions Oncology's Net Margin had a median value of 1.92% in 2022 and averaged 3.51%.
- As far as peak fluctuations go, Champions Oncology's Net Margin plummeted by -250600bps in 2023, and later surged by 474300bps in 2025.
- Over the past 5 years, Champions Oncology's Net Margin (Quarter) stood at 2.35% in 2021, then plummeted by -105bps to 0.11% in 2022, then plummeted by -15872bps to 17.9% in 2023, then surged by 130bps to 5.4% in 2024, then crashed by -71bps to 1.58% in 2025.
- Its Net Margin was 1.58% in Q4 2025, compared to 3.33% in Q3 2025 and 14.85% in Q2 2025.